The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Discordant treatment response in primary tumors and lymph node metastases after four weeks of preoperative PD-1 blockade in head and neck squamous cell carcinoma (HNSCC).
 
Adam Luginbuhl
No Relationships to Disclose
 
Jennifer Maria Johnson
No Relationships to Disclose
 
Madalina Tuluc
No Relationships to Disclose
 
Stacey Mardekian
No Relationships to Disclose
 
Larry Harshyne
No Relationships to Disclose
 
Benjamin Leiby
Consulting or Advisory Role - Bayer
 
Ralph Zinner
Employment - Merck (I)
Stock and Other Ownership Interests - Merck (I)
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck (I)
 
Joseph M. Curry
Research Funding - AstraZeneca
 
David M. Cognetti
No Relationships to Disclose
 
Ulrich Rodeck
Stock and Other Ownership Interests - Akriveia Therapeutics; Akriveia Therapeutics
Research Funding - Advaxis
Patents, Royalties, Other Intellectual Property - Royalties related to several patents
 
Athanassios Argiris
Consulting or Advisory Role - Aspyrian Therapeutics; Bristol-Myers Squibb; Debiopharm Group; Merck Serono; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono
Research Funding - Bristol-Myers Squibb; Genentech/Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono